ABOUT
YnnoMed is a drug R&D platform dedicated to addressing the unmet clinical needs of new antimicrobial agents tackling antimicrobial resistance. Our goal is to design, develop, and distribute first-in-class antimicrobial medicines that can treat current antibiotic-resistant bacterial infections, and suppress the generation of new antimicrobial resistance. We also are able to provide drug design and discovery services by using our AI-assisted drug discovery technologies.
Awards & Participations
TechConnect 2019
Global Innovation Award
"New Antibiotic Drug Candidates" invented by Dr Cong MA, Assistant Professor, Department of Applied Biology and Chemical Technology, PolyU, and Dr Xiao YANG, Research Assistant Professor, Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong
Falling Walls Breakthroughs of the Year 2023 Global Call
Winner, Science Start-ups / Falling Walls Venture
The ONLY company from Hong Kong named as one of 25 Winners in the category of Science Start-ups (Falling Walls Venture) out of 113 Finalists. Participated at Falling Walls Science Summit 2023 and presented at Falling Walls Venture Pitch Day held in Berlin in November 2023.
48th International Exhibition of Inventions Geneva
Exhibitor representing CUHK, Hong Kong delegation
Bronze Medalist
Classe M - Médecine - Chirurgie - Hygiène - Orthopédie - Matériel pour handicapés:
"Série de petites molécules chimiques dont l'efficacité a été prouvée pour éliminer les bactéries pathogènes. Ces molécules antimicrobiennes ont un nouveau mécanisme d'action et un fort potentiel en tant que nouveaux candidats antibiotiques."
CUHK Innovation Day 2022
Champion
"The first Elevator Pitch Competition was also held this year. 13 TSSSU-funded companies competed for four awards, delivering two-minute pitches that introduced their latest research projects. Ynno Med Limited, founded by Professor Yang Xiao, Assistant Professor, Department of Microbiology, Faculty of Medicine won the championship (please see Appendix for the winner list)."
As seen at:
BIO International Convention 2024
Exhibitor (1 of 16 companies from HKSTP delegation)
South China Morning Post: //Hong Kong’s delegation to San Diego includes local start-up YnnoMed, whose work focuses on developing newantibiotics that can tackle more resilient superbugs.//
Read More . . . (1)
The Standard: //YnnoMed is leading the charge in developing groundbreaking AMR medicines. Preliminary results from their preclinical studies are very promising. YnnoMed has progressed its drug candidate to clinical trials and formed a strategic partnership with Shanghai Pharmaceuticals Holding to expedite their approval process in Mainland China.//
Read More . . . (2)
明報：//研發新型抗生素的生物科技初創公司元美藥業亦會赴美參展，該公司共同創辦人馬聰是理工大學應用生物及化學科技學系副教授，與團隊早於2019年成功研發新一代候選抗生素，及後成立公司冀推動商品化。馬向本報稱，團隊已與上海醫藥成為合作伙伴，稍後在內地開展第一至三期臨牀測試，以取得國家藥品監督管理局藥物註冊。他稱，上海醫藥業務重心在內地，冀藉此行接觸國際投資者或跨國藥廠，助同步打入國際市場。//
Read More . . . (3)
Asia Summit on Global Health 2024
Exhibitor
ORKTS: Themed “Innovation．Inclusion．Impact”, ASGH is a one-stop cross-disciplinary platform that will bring together all stakeholders from around the world to exchange insights, explore opportunities and collaborate on the diverse and dynamic healthcare sector. As one of the main supporting exhibitors, the CUHK and its start-up companies displayed wide-range of biomedical technologies to escalate development in the healthcare sectors and to promote a sustainable future.
// Ynno Med Limited (Prof. Xiao YANG, Faculty of Medicine / Department of Microbiology) //
Read More . . . (1)
CUHK Innovation Summit 2024
Pitch Presenter
Boehringer Ingelheim Innovation Prize 2023
Pitch Presenter
"Think Business, Think Hong Kong" Symposium in Paris + HKTDC Healthcare Mission to Paris & Berlin
Exhibitor + Delegate
BioHK 2023
Exhibitor
Asia Summit on Global Health 2023 +
14th HKTDC Hong Kong International Medical and Healthcare Fair
Exhibitor
BioHK 2022
Exhibitor
CU Medicine x HKSTP
Health Innovation & Technology Summit 2022
Exhibitor
Asia Summit on Global Health 2021
Exhibitor
Meet Our Co-Founders
Prof. Xiao Yang
Prof. Yang is a microbiologist with rich experience in the research of bacterial transcription. She identified an RNA polymerase subunit in Bacillus subtilis and the encoding gene was named after her as rpoY.
Prof. Cong Ma
Prof. Ma is dedicated to medicinal chemistry and drug discovery. He leads a team to design and discover a series of first-in-class antimicrobial agents targeting protein-protein interactions in bacterial transcription.
Pipelines
What makes us special?
